Teverelix (EP 24332) is a GnRH antagonist. Teverelix binds competitively and reversibly to GnRH receptors, thereby suppressing the release of LH and FSH. Teverelix can be used in the research of prostatic hyperplasia, endometriosis, and prostate cancer[1
Molecular Weight:
1459.13
CAS Number:
[151272-78-5]
Formula:
C74H100ClN15O14
Target:
GnRH Receptor,Histamine Receptor
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted